Written by Kaunain Sheriff M | New Delhi | Updated: September 7, 2020 6:56:29 am The candidate vaccine elicited a “strong” immune response in Phases 1 and 2 of clinical trials in 76 people. (AP Photo) Even when the Lancet published the data from the phase 1 and phase 2 …
Read More »Russia Shares Vaccine Data With India, One Option Is Phase 3 Trials Here
